Teleflex Incorporated
$ 122.76
0.35%
26 Dec - close price
- Market Cap 5,425,306,000 USD
- Current Price $ 122.76
- High / Low $ 123.00 / 121.24
- Stock P/E N/A
- Book Value 86.48
- EPS -7.17
- Next Earning Report 2026-02-19
- Dividend Per Share $1.36
- Dividend Yield 1.11 %
- Next Dividend Date -
- ROA 0.05 %
- ROE -0.08 %
- 52 Week High 183.89
- 52 Week Low 102.26
About
Teleflex Incorporated (TFX), based in Wayne, Pennsylvania, is a leading global provider of innovative medical devices focused on critical care and surgical applications. The company offers a comprehensive range of specialty products designed to enhance patient safety and improve outcomes across a variety of medical procedures. With a strong commitment to innovation and high-quality standards, Teleflex has established itself as a trusted partner for clinicians and patients worldwide, continually driving advancements in medical technology and reinforcing its position as a leader in the healthcare industry.
Analyst Target Price
$132.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-07-30 | 2025-04-30 | 2025-02-20 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-22 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-02-23 |
| Reported EPS | 3.67 | 3.73 | 2.91 | 3.89 | 3.49 | 3.42 | 3.21 | 3.38 | 3.64 | 3.41 | 3.09 | 3.52 |
| Estimated EPS | 3.38 | 3.36 | 2.8842 | 3.875 | 3.39 | 3.33 | 3.07 | 3.26 | 3.27 | 3.21 | 2.97 | 3.44 |
| Surprise | 0.29 | 0.37 | 0.0258 | 0.015 | 0.1 | 0.09 | 0.14 | 0.12 | 0.37 | 0.2 | 0.12 | 0.08 |
| Surprise Percentage | 8.5799% | 11.0119% | 0.8945% | 0.3871% | 2.9499% | 2.7027% | 4.5603% | 3.681% | 11.315% | 6.2305% | 4.0404% | 2.3256% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 4.05 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-15 | 2025-09-15 | 2025-06-16 | 2025-03-17 | 2024-12-16 | 2024-09-16 | 2024-06-14 | 2024-03-15 | 2023-12-15 | 2023-09-15 |
| Amount | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 | $0.34 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TFX
2025-12-22 12:08:31
Wedge Capital Management L L P NC initiated a new position in Teleflex Incorporated (NYSE:TFX) by purchasing 220,082 shares valued at approximately $26.93 million. This comes as Teleflex reported strong quarterly earnings, beating EPS estimates and achieving a 19.4% year-over-year revenue increase. Despite the positive earnings and institutional ownership of 95.62%, analyst ratings are largely mixed, with a consensus price target of $142.43 against a current trading price near $121.73.
2025-12-22 11:08:41
Teleflex Inc. stock underperformed on Friday compared to its competitors. The article mentions Unity Software's fourth-quarter financial results, irrelevant to Teleflex's performance, indicating a likely content aggregation error. The core assertion is Teleflex's underperformance, not Unity's earnings.
2025-12-18 15:09:29
Truist Securities has increased its price target for Teleflex (TFX) shares to $135, up from $120, while maintaining a Hold rating on the stock. This adjustment comes after other analysts also recently updated their targets for the medical technology company. The article notes several other recent analyst actions and company news, including Teleflex's plans to divest three businesses for $2.03 billion.
2025-12-17 20:09:27
Intersurgical has agreed to acquire the Acute Care and Interventional Urology businesses from Teleflex for $530 million. This acquisition aims to expand Intersurgical's product portfolio and operational capacity, creating a broader suite of solutions for customers worldwide. The transaction is expected to be completed in the second half of 2026, subject to regulatory approvals.
2025-12-17 12:09:27
Zacks Research has adjusted its Q3 2026 EPS estimate for Teleflex (NYSE:TFX) to $3.88, down from $3.90, while maintaining a "Hold" rating. The medical technology company's last reported Q3 earnings on November 6th showed an EPS of $3.67, surpassing the consensus of $3.38, and revenue of $892.9 million, an increase of 19.4% year-over-year. Teleflex has also set its FY2025 EPS guidance between $14.00 and $14.20.
2025-12-16 21:09:44
Teleflex Incorporated (NYSE: TFX) has agreed to sell three non-core businesses for a combined $2.03 billion in cash, aiming to sharpen its focus on higher-growth segments like vascular access and interventional technologies. The company plans to use the estimated $1.8 billion net proceeds to pay down debt and fund a new $1 billion share repurchase program. This strategic move is expected to streamline Teleflex's operations and enhance shareholder returns.
